After five years as Editor in Chief, Professor Wei Wang has retired from this important and influential role with Family Medicine and Community Health (FMCH). The new Editor in Chief is Professor Li Li, Professor of Family Medicine, Epidemiology and Biostatistics, and Mary Ann Swetland Professor of Environmental Health Sciences and Director of Mary Ann Swetland Center for Environmental Health at Case Western Reserve University, Cleveland, Ohio, USA.
The Publisher would like to thank Professor Wang for his hard work on behalf of Family Medicine and Community Health over the last five years. During Professor Wang’s editorship the submissions to FMCH have seen significant growth and the journal has enjoyed several major achievements including having FMCH indexed in Clarivate Emerging Sources Citation Index (ESCI), Scopus, DOAJ (Directory of Open Access Journals), WPRIM (Western Pacific Index Medicus), EBSCO, OCLC, Primo Central (Ex Libris), Sherpa Romeo, Ulrichsweb, NISC and Index Copernicus Databases. The journal’s development and profile have benefited greatly from Professor Wang’s wealth of expertise in the field of family medicine and community health, and the extensive links he has with general practitioners and researchers throughout the world.
We would like to welcome Professor Li Li, the new Editor-in-Chief. This change in leadership marks the beginning of a new stage of development. Maintaining the broad scope, encompassing all areas of epidemiology, public health, social and preventive medicine, research and evidence-based medicine, community health service, patient education and health promotion and health ethics, the journal shall build on substantial international support to strive for a more consistently higher standard of publication. The journal will continue to publish all types of research from clinical practice, to education and training to management of community health centers.
We look forward to working with Professor Li Li as we continue to make Family Medicine and Community Health a success.
Professor Li Li Biography
Li Li, MD, PhD, is Professor of Family Medicine, Epidemiology and Biostatistics, and Mary Ann Swetland Professor of Environmental Health Sciences and Director of Mary Ann Swetland Center for Environmental Health at Case Western Reserve University, Ohio, USA.
Professor Li is also Associate Director for Prevention Research of the Case Comprehensive Cancer Center. He is board-certified in Family Medicine and maintains an active clinical practice at University Hospitals Cleveland Medical Center. He has recently been elected as Director-at-Large of the American Society of Preventive Oncology (ASPO).
Professor Li completed his training in medicine and public health at Tongji Medical University, Wuhan, China in 1989. He obtained his M.S. in Biometry in 1995, and Ph.D. in Preventive Medicine in 1996 from the University of Southern California (USC), California, USA. He pursued his fellowship in cancer prevention at the US National Cancer Institute (NCI), Bethesda, Maryland, USA, from 1996 to 1997, followed by a clinical residency in Family Medicine from 1997 to 2000 at the University of Kentucky, Lexington, Kentucky, USA. He was a Damon-Runyon Clinical Investigator (2001 to 2006) supported by a prestigious career development award from the Damon-Runyon Cancer Research Foundation.
Professor Li’s research is centered at the intersection of molecule and population, with focuses on the interface of primary care and translational preventive oncology. To this end, he is pursuing research to understand the complex interplay among environment, energy imbalance, genome, and more recently gut microbiome, and cancer health disparities. He established the relatively large population-based Kentucky SEER-based Colon Cancer Genetic Epidemiology Study and the Cleveland Colon Screening Cohort study. He is PI of a NCI U01 to examine 15-PGDH as a novel biomarker of individualized colon chemoprevention using NSAIDs. He has co-led a main project in the Case Comprehensive Cancer Center GI Special Program of Research Excellence (SPORE) program that examined the efficacy and racial difference of stool DNA methylation (sDNA) testing for early detection of colon neoplasia, which is now a FDA approved test for colon cancer screening. He continues to co-lead 2 main projects in the recently renewed Case Comprehensive Cancer Center GI SPORE, one of the only 3 SPOREs funded by NCI in US focusing on GI malignancies, that examine racial differences of genomic underpinnings for colon neoplasia and 15-PGDH as a marker for precision prevention of colon neoplasia. Dr. Li has made significant contribution to the Oxford University-led international consortium for Colon Cancer Gene Discovery (CoGENT), and the USC-led Colorectal Transdisciplinary Study (CORECT) consortium.
As Associate Director for Prevention Research at Case Comprehensive Cancer Center, Professor Li oversees and promotes research that cuts across all aspects of population sciences ranging from epidemiology and behavioral sciences to genomics and prevention. He is passionate about mentoring and training. He is PI of a NCI-funded T32 (previously R25) training program on Computational Genomic Epidemiology of Cancer (CoGEC) at Case Comprehensive Cancer Center. He founded the Clinical Translational Science PhD program at Case Western Reserve University in 2015. He is also director of the Case-China Health Initiative, a program established in 2010 that promotes medical student exchange between CWRU School of Medicine and major Chinese Universities, to train family and community physicians in China. He is co-author of “Handbook for General Medicine Residents” recently published (2017) in Chinese by the China People’s Health Press.